U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07432932) titled 'Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients' on May 26, 2022.
Brief Summary: This is a cohort study aimed at developing a stratified medicine approach for personalised neoadjuvant chemotherapy (NCT) in high-risk soft tissue sarcoma (STS) patients with dedifferentiated liposarcoma (DDLPS), leiomyosarcoma (LMS), synovial sarcoma (SS), vascular sarcomas, malignant peripheral nerve sheath tumour (MPNST) or other subtypes. It comprises of both retrospective and prospective tissue collection from patients advancing directly to surgery (control group) and patients receiving NCT and surgery.
Study St...